Editorial: Evolving Models for Hepatocellular Carcinoma Prognostication
- 18 October 2026
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- ALBI ‐6—A Novel Prognostic Score Combining ALBI and Interleukin‐6 in Patients With HCC Treated With Atezolizumab and BevacizumabAlimentary Pharmacology & Therapeutics, 2026
- Machine learning based radiomic models outperform clinical biomarkers in predicting outcomes after immunotherapy for hepatocellular carcinomaJournal of Hepatology, 2025
- Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspectiveClinical and Molecular Hepatology, 2023